Genmab AS

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 4343.88, 5190.41, 6304.17, 6753.45, 7024.88 ], "ebit_estimate": [ 1213.73, 1679.01, 2334.67, 2428.87, 2585.55 ], "ebitda_estimate": [ 1250.65, 2000.32, 2956.96, 3466, 3181 ], "net_income_estimate": [ 734.15, 1151.76, 1725.16, 1897.95, 2181.47 ], "per_share_eps_estimate": [ 1.21, 1.74, 2.83, 8.27, 2.91 ], "eps_nri_estimate": [ 1.17, 1.75, 2.77, 2.64, 3.94 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 104.53, 126.39, 160.24, null, null ], "pretax_income_estimate": [ 932.06, 1465.61, 2185.03, 2354.24, 2550.38 ], "operating_cash_flow_per_share_estimate": [ 1.11, 2.26, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ 10.89, 16.24, 21.4, null, null ], "gross_margin_estimate": [ 94.4, 91.7, 89.2, 85, 82 ], "operating_cash_flow_estimate": [ 708.8, 1443.13, null, null, null ], "pettm_estimate": [ 23.97, 16.67, 10.27, 3.51, 9.97 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "17.71", "future_per_share_eps_estimate_growth": 20.23, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 17.71, "future_ebit_estimate_growth": 26.65, "future_ebitda_estimate_growth": 26.17, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": 20.66, "future_book_value_per_share_estimate_growth": 15.03, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -0.92, "future_operating_cash_flow_per_share_estimate_growth": 12.79 }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 1097.84, 1174.74, 1193.33, 1058.29, 1251.42, 1338.2, 1467.43, 1239.33 ], "ebit_estimate": [ 345.35, 382.08, 357.03, 225.7, 495, 587.7, 612.7, null ], "ebitda_estimate": [ 471.92, 535.5, 438.96, null, null, null, null, null ], "net_income_estimate": [ 215.04, 246.79, 239.09, 117, 328.1, 402.1, 423.8, null ], "per_share_eps_estimate": [ 0.35, 0.39, 0.39, 0.26, 0.3, 0.35, 0.5, null ], "eps_nri_estimate": [ 0.34, 0.36, 0.36, 0.18, 0.44, 0.5, 0.53, null ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ 278.56, 311.72, 295.49, 201.5, 360.8, 430.8, 539.65, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 94, 94, 94, 93, 92, 90, 88, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 20.92, 21.69, 22.27, 20.55, null, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "17.71", "future_per_share_eps_estimate_growth": 20.23, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 17.71, "future_ebit_estimate_growth": 26.65, "future_ebitda_estimate_growth": 26.17, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": 20.66, "future_book_value_per_share_estimate_growth": 15.03, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -0.92, "future_operating_cash_flow_per_share_estimate_growth": 12.79 }